Summary of Purpose
A prospective, multi-center, randomized, sham-controlled, blinded study combining active Nexstim NBS-guided 1Hz rTMS or sham-rTMS targeting the healthy hemisphere with standardized task oriented rehabilitation will be conducted in patients with post-stroke motor impairment of the upper limb. The therapy will be provided for 6 weeks and primary outcome assessed 6 months later.Read More →
The following dates are available for this trial. Trial information last updated on 23 January 2018.
|1 Mar 2017||3 Jan 2017||1 Jun 2018||1 Jun 2018||1 Jan 2018||Unavailable|
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Nexstim Ltd Lead
- Jarmo Laine, MD